ArticleEmerging infectious diseases2017
No Such Thing as Chronic Q Fever.
Article in Emerging infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 35 citations in OpenAlex.
- First Survey on the Seroprevalence ofPathogens (Basel, Switzerland) · 2025Article
- Genome-wide epitope mapping across multiple host species reveals significant diversity in antibody responses toFrontiers in immunology · 2023Article
- Screening forJournal of veterinary research · 2022Article
- Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases.The Journal of biological chemistry · 2022Article
- Pangenomic analysis ofFrontiers in microbiology · 2022Article
- Correlating Genotyping Data ofPathogens (Basel, Switzerland) · 2021Article
- Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity.NPJ vaccines · 2021Article
- Reactivation of Q fever: case report of osteoarticular infection developing at the site of a soft tissue injury.Access microbiology · 2021Article
- In the Search of Potential Serodiagnostic Proteins to Discriminate Between Acute and Chronic Q Fever in Humans. Some Promising Outcomes.Frontiers in cellular and infection microbiology · 2020Article
- Risk of chronic Q fever in patients with cardiac valvulopathy, seven years after a large epidemic in the Netherlands.PloS one · 2019Article
- The prevalence of Coxiella burnetii shedding in dairy goats at the time of parturition in an endemically infected enterprise and associated milk yield losses.BMC veterinary research · 2018Article
- Viable Coxiella burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella burnetii.Infection and immunity · 2018Article
- Should Acute Q-Fever Patients be Screened for Valvulopathy to Prevent Endocarditis?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Article
- Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine.Human vaccines & immunotherapeutics · 2017Review
- Zoonoses under our noses.Microbes and infectionReview
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modern diagnostic methods enable clinicians to look beyond a diagnosis of chronic Q fever and discern whether patients instead have persistent focalized Coxiella burnetii infection(s). Use of these methods and development of criteria to define and treat such infections, especially cardiovascular infections, will improve the prognosis for patients previously thought to have chronic Q fever.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.